Michelle Simone Clement

TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma

Stine Karlsen Oversoe, Michelle Simone Clement, Michael Pedersen et al. · Scandinavian Journal of Gastroenterology · 2020 · 41 citations

Medicine, Molecular Genetics, Oncology +17

Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients

Johanne Andersen Højbjerg, Eva Boysen Fynboe Ebert, Michelle Simone Clement et al. · Lung Cancer · 2019 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells

Michelle Simone Clement, Kristine Raaby Gammelgaard, Anders Lade Nielsen et al. · Translational Lung Cancer Research · 2020 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC

Kristine Raaby Gammelgaard, Johan Vad‐Nielsen, Michelle Simone Clement et al. · Translational Oncology · 2018 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma

Stine Karlsen Oversoe, Michelle Simone Clement, Britta Weber et al. · BMC Cancer · 2021 · 22 citations · Full text

Medicine, Molecular Genetics, Oncology +17